Recruiting Psoriasis Studies in Fountain Valley
About Psoriasis Clinical Trials in Fountain Valley
Psoriasis is a chronic autoimmune skin condition affecting over 8 million Americans, causing cells to build up rapidly on the surface and forming red, scaly patches that can be itchy and painful. Plaque psoriasis accounts for about 80-90% of cases. While current treatments include topical therapies, phototherapy, and biologics like TNF inhibitors (adalimumab, etanercept) and IL-17/IL-23 inhibitors (secukinumab, guselkumab), clinical trials are testing next-generation oral treatments, TYK2 inhibitors, and combination approaches that may offer longer remission periods with fewer side effects. Patients with moderate-to-severe psoriasis who have not responded adequately to existing therapies are often sought for clinical trial enrollment.
There are currently 11 psoriasis clinical trials recruiting participants in Fountain Valley, CA. These studies are seeking a combined 6,674 participants. Research is being sponsored by Bristol-Myers Squibb, Takeda, Oruka Therapeutics, Inc. and 4 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.
Psoriasis Clinical Trials in Fountain Valley — FAQ
Are there psoriasis clinical trials in Fountain Valley?
Yes, there are 11 psoriasis clinical trials currently recruiting in Fountain Valley, CA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Fountain Valley?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Fountain Valley research site will contact you about next steps.
Are clinical trials in Fountain Valley free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Fountain Valley studies also compensate for your time and travel.
What psoriasis treatments are being tested?
The 11 active trials in Fountain Valley are testing new therapies including novel drugs, biologics, and treatment approaches for psoriasis.
Data updated July 17, 2026 from ClinicalTrials.gov